NitriCap is a single-use antimicrobial catheter insert device that uses breakthrough nitric oxide-eluting technology to fight catheter-related bloodstream infections.
During an in-clinic dialysis session (3 times / week), caps to access each TDC lumen are removed for dialysis procedure access.
Bacteria is most often introduced into TDC at hub. It then adheres to biofilm (a thin slimy film) or activated platelets (clots) inside TDC which lead to bloodstream infections.
NitriCap inserts are secured into catheter hub and remain in place between hemodialysis treatments.
Once inserted, NitriCap's patent-pending technology releases precise quantities of nitric oxide into catheter hub to kill bacteria, disperse biofilm, and inhibit platelet aggregation.
In vivo large animal studies show NitriCap reduces bacteria colony-forming units (CFU) by 10,000 fold as compared to the leading competitor throughout catheter.
NitriCap's breakthrough technology can reduce bloodstream infections across other infusion catheter segments with a total market opportunity of over $900M.
For investigational use only. Not available for commercial sale
Copyright © 2020 NitriCap Medical Inc. - All Rights Reserved.